Ngo Linh, Ali Anna, Ganesan Anand, Woodman Richard, Adams Robert, Ranasinghe Isuru
The Northside Clinical Unit, School of Clinical Medicine, Faculty of Medicine, The University of Queensland, Brisbane, 4032, QLD, Australia.
Department of Cardiology, The Prince Charles Hospital, Brisbane, 4032, QLD, Australia.
Eur Heart J Qual Care Clin Outcomes. 2021 Sep 16;7(5):458-467. doi: 10.1093/ehjqcco/qcab035.
Population studies that provide unbiased estimates of gender differences in risk of complications following catheter ablation of atrial fibrillation (AF) are sparse. We sought to evaluate the association of female gender and risk of complications following AF ablation in a nationwide cohort.
We identified 35 211 patients (29.5% females) undergoing AF ablations from 2008 to 2017 using national hospitalization data from Australia and New Zealand. The primary outcome was any procedural complication occurring up to 30-days after discharge. Logistic regression was used to adjust for differences in baseline characteristics between sexes. Compared with males, females were older (mean age 64.9 vs. 61.2 years), had higher rates of hypertension (14.0% vs. 11.6%) and haematological disorders (5.3% vs. 3.8%) and experienced a higher rate of procedural complications (6.96% vs. 5.41%) (all P < 0.001). This gender disparity remained significant after adjustment [odds ratio (OR) 1.25 (95% confidence interval 1.14-1.38), P < 0.001] and was driven by an increased risk of vascular injury [OR 1.86 (1.23-2.82), P = 0.003], pericarditis [OR 1.86 (1.16-2.67), P = 0.008], pericardial effusion [OR 1.71 (1.35-2.17), P < 0.001), and bleeding [OR 1.30 (1.15-1.46), P < 0.001]. Notably, the gender difference persisted over time [OR for the most recent period 1.19 (1.003-1.422), P = 0.046] despite a declining complication rate in both men and women.
Females undergoing AF ablations experienced a 25% higher risk of procedural complications compared with males, a disparity that has persisted over time despite a falling complication rate. Efforts to reduce this gender disparity should focus on reducing the incidence of pericardial effusion, pericarditis, vascular injury, and bleeding.
能够对房颤(AF)导管消融术后并发症风险的性别差异提供无偏估计的人群研究较少。我们试图在一个全国性队列中评估女性性别与房颤消融术后并发症风险之间的关联。
我们利用澳大利亚和新西兰的全国住院数据,确定了2008年至2017年间接受房颤消融术的35211例患者(29.5%为女性)。主要结局是出院后30天内发生的任何手术并发症。采用逻辑回归对性别之间的基线特征差异进行校正。与男性相比,女性年龄更大(平均年龄64.9岁对61.2岁),高血压(14.0%对11.6%)和血液系统疾病(5.3%对3.8%)发生率更高,手术并发症发生率也更高(6.96%对5.41%)(所有P<0.001)。校正后这种性别差异仍然显著[比值比(OR)1.25(95%置信区间1.14 - 1.38),P<0.001],并且是由血管损伤风险增加[OR 1.86(1.23 - 2.82),P = 0.003]、心包炎[OR 1.86(1.16 - 2.67),P = 0.008]、心包积液[OR 1.71(1.35 - 2.17),P<0.001]和出血[OR 1.30(1.15 - 1.46),P<0.001]所驱动。值得注意的是,尽管男性和女性的并发症发生率都在下降,但性别差异随时间持续存在[最近时期的OR为1.19(1.003 - 1.422),P = 0.046]。
接受房颤消融术的女性手术并发症风险比男性高25%,尽管并发症发生率在下降,但这种差异随时间持续存在。减少这种性别差异的努力应集中在降低心包积液、心包炎、血管损伤和出血的发生率上。